Categories
Sai Life Sciences Limited — Board Meeting, 14-05-2026: Outcome of Board Meeting
14-05-2026 · 10:59 pm
Sai Life Sciences' board approved its Q4 & FY26 consolidated results. Full-year revenue reached ₹2192.49 Cr, with profit at ₹348.91 Cr. The company fully utilized its ₹909.88 Cr IPO proceeds for debt repayment and general corporate purposes.
No comments yet. Be the first to comment!